|
|
Position:
VP of Boston Innovation Center
Employer:
Simcere of America Inc.
Description:
-
Manage operation of Boston Innovation Drug R&D Center, lead the team to introduce new products; manage and guide progress, quality of innovative drug R&D projects to ensure R&D work completed on time
-
Formulate mid and long-term strategies plans based on industry and company development trends
-
Evaluate, introduce external innovation drug R&D projects upon the company’s R&D pipeline and strategy
-
In-depth explore the development trend of the pharmaceutical industry. Make and implement key projects
-
Resolve key problems in the research and development of innovative drugs. Coordinate among teams
-
全面波士顿创新药药研发中心各项管理工作,带领团队做好新产品立项,对创新药研发项目的进 度和质量进行监督、管理和指导,确保研发工作按时保质完成
-
根据行业及企业发展趋势,制定波士顿创新药研发中心的中长期策略和发展计划
-
根据公司研发管线布局和规划,对外部创新药研发项目进行评估和引进
-
组织研究医药行业发展方向及政策,制定和实施重大研发项目决策方案
-
负责创新药研发过程中疑难问题的攻关和相关组织、部门之间工作协调
Qualifications/Experience:
-
Ph.D. degree in pharmaceutical-related professions, more than 10 years’ experience in pharmaceutical R&D, experience in R&D team management, and priority in large pharmaceutical companies, transnational companies or overseas working experience
-
Outstanding insights on pharmaceutical policies and excellent information research and analysis capabilities. Judge the next step of R&D priorities and coping strategies based on the analysis results
-
Conduct topic selection, establishment, development and application of new drugs, organize and promote the development, implementation, and management of new drug R&D projects, and formulate schedules for new drug R&D projects.
-
医药类相关专业博士学历,十年以上医药研发工作经验,具有丰富的研发团队管理经验,有大型 药企、外企或海外工作经验者优先;
-
具有突出的对国家药品、新药政策敏锐的洞察力和优秀的信息调研分析能力,能够根据分析结果 判断下一步研发工作重点和应对策略;
-
能进行新药的选题、立项、研制、申报工作,并组织、推进新药研发项目的开发、实施、管理, 制定新药研发项目的进度计划。
Location:
Boston
Contact:
Chen Chen (chen.chen@simcereusa.com)
Post Date:
11/6/2018 2:19:59 PM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Submit a Text Ad
|